迈得医疗(688310.SH)：2025年三季报净利润为883.67万元

Core Insights - The company reported a total revenue of 225 million yuan for Q3 2025, with a net profit attributable to shareholders of 8.84 million yuan and a net cash inflow from operating activities of 126 million yuan [1]. Financial Performance - The latest debt-to-asset ratio stands at 29.86%, which is an increase of 1.49 percentage points from the previous quarter and an increase of 13.62 percentage points compared to the same period last year [3]. - The company's gross profit margin is 40.19%, reflecting a decrease of 6.70 percentage points from the same period last year [3]. - The return on equity (ROE) is reported at 1.10% [3]. - The diluted earnings per share (EPS) is 0.05 yuan [3]. - The total asset turnover ratio is 0.20 times, while the inventory turnover ratio is 0.80 times [3]. Shareholder Structure - The number of shareholders is 4,528, with the top ten shareholders holding a total of 120 million shares, accounting for 72.36% of the total share capital [3]. - The largest shareholder is Lin Junhua, holding 47.1 million shares [3]. - Other notable shareholders include Chen Wanshun with 14.8 million shares and Taizhou Saina Investment Consulting Partnership with 3.45 million shares [3].